As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
All content for Built Environment Matters is the property of Bryden Wood and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
Navigating the Energy Debate: Challenges and Solutions | Martin Wood, Adrian La Porta and John Dyson
Built Environment Matters
39 minutes
6 months ago
Navigating the Energy Debate: Challenges and Solutions | Martin Wood, Adrian La Porta and John Dyson
Join Bryden Wood's co-founder Martin Wood, Technical Director Adrian La Porta, and Professor John Dyson as they discuss the critical state of the global energy grid. Triggered by recent power outages in Spain and Portugal, this episode uncovers the hidden complexities of integrating renewables, the intensifying demand from new technologies like AI, and the debate over centralised vs. distributed power. They explore the concept of ‘network value’ for energy sources, the challenges and opportun...
Built Environment Matters
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
